Management

brayan

Bryan Staker

Founder, Chief Executive Officer

Bryan Staker serves as Chief Executive Officer and Founder at Apton Biosystems. Bryan is a seasoned bio-tech and high-tech startup veteran with over 20 years of experience at previous startups including Complete Genomics (Dir. of Hardware), Glimmerglass Networks (Chief Technologist) and Silicon Light Machines (Sr. Engineer).He has been an integral part of leading teams that have successfully brought technologies from scratch to market in disparate fields such as DNA sequencing, optical telecommunications, display and print. Bryan is skilled in electrical, silicon, optical and mechanical engineering with a strong background in algorithm development, multi-physics modeling and software, He has an M.S. degree in Applied Physics from Stanford University and an M.S. degree in Electrical Engineering and B.S. degree in Physics from Brigham Young University. He has 30+ issued and 20+ pending U.S. patents.

linda

Linda Liu

Founder, Chief Corporate Development Officer

Linda Liu serves as Chief Corporate Development Officer at Apton. Her current responsibilities include business development, product management, and fund raising. Linda is a co-founder of Apton and co-inventor of Apton’s core technology. She is heavily involved in collaborations and established Apton’s scientific advisory board. Linda has 20 years of experience in instrument and consumable based business across a variety of platforms such as DNA sequencing, DNA microarrays, and multiplexed immunoassays from early research, development to manufacturing. Prior to Apton, Linda was a manager/scientist in companies including Life Technologies, Aclara Biosciences and Protogene laboratories. Linda received a B.S. in Biology and a M.S. in Plant Physiology from Xiamen University and a M.S. in Biochemistry from the University of Louisiana.

Manohar Furtado Photo 1

Manohar Furtado

Chief Scientific Officer, Chief Regulatory Officer, Ph.D.

Manohar R. Furtado is the CSO and CRO at Apton and leads the Biology and Chemistry efforts. He was on the Faculty at Northwestern and the CLIA lab Director at NMH. He has 20+years experience in launching systems integrating biology, chemistry, software & hardware for sequencing, gene expression, genotyping, and pathogen detection. He was the VP R & D, for Molecular Medicine and Applied Markets at ABIand commercialized products for molecular diagnostics, HIDanimal health, food pathogens, pharmaceutical QA/QC and environmental/biothreat applications. He also served as the Sr. Director, Regulatory at Cepheid to enable IVDD kit launches. He enabled diagnostics products at ACD, Bio-Rad, and Vibrant Health. He was appointed to the NBSB by Kathleen Sibelius in 2011. He has a Ph.D. in Biologytraining in Virology from NUMS and a business certification from MIT. He has 100 publications in peer-reviewed journals and several patents issued.

dennis_ballinger

Dennis Ballinger

VP of R&D - Ph.D.

Dennis Ballinger, Ph.D., has served as Apton Biosystems’ Vice President of Research and Development since December 2017. Prior to joining Apton he was the Vice President of Genomics at Complete Genomics where he led the biochemical development of next generation sequencing platforms, and at Perlegen Sciences, leading the interpretation of genomic datasets. Prior to that, he served as Director of Product Development at Ingenuity Systems, Inc., developing their genomic interpretation tools, as Senior Director of Functional Genomics at Hyseq, Inc and Director of Cardiovascular Disease Research at Myriad Genetics. Dr. Ballinger was an Assistant Professor of molecular biology at the Sloan-Kettering Institute and Cornell University Graduate School. He completed his postdoctoral training at the California Institute of Technology, received a Ph.D. in cellular and developmental biology from the Massachusetts Institute of Technology, and a B.S. in molecular cell biology from University of Colorado, Boulder.

Jim

Jim Jahncke

VP of Engineering

Jim Jahncke is VP of Engineering of Apton Biosystems. His responsibilities include overseeing instrument and consumable development efforts. Jim has 20+ years of experience in managing high performance engineering teams. Prior to joining Apton, Jim served as Senior Director at Molecular Devices, focused on delivering solutions to enable research in cell and protein biology. Jim holds a BS degree in Computer Science.

FullSizeRender

Scott Gorton

Chief Financial Officer

Scott Gorton is CFO of Apton Biosystems. Scott has 20+ years of experience in senior finance positions with companies ranging from startups to multinationals. Prior to joining Apton, Scott served as CFO of Precursor Energetics and VP Finance of Glimmerglass Networks. Previously, he held senior positions with IBM and Siemens. Scott holds a BA degree from Cornell University and an MBA from The Wharton School.

Board Of Directors

brayan

Bryan Staker

Founder, Chief Executive Officer

Bryan Staker serves as Chief Executive Officer and Founder at Apton Biosystems. Bryan is a seasoned bio-tech and high-tech startup veteran with over 20 years of experience at previous startups including Complete Genomics (Dir. of Hardware), Glimmerglass Networks (Chief Technologist) and Silicon Light Machines (Sr. Engineer).He has been an integral part of leading teams that have successfully brought technologies from scratch to market in disparate fields such as DNA sequencing, optical telecommunications, display and print. Bryan is skilled in electrical, silicon, optical and mechanical engineering with a strong background in algorithm development, multi-physics modeling and software, He has an M.S. degree in Applied Physics from Stanford University and an M.S. degree in Electrical Engineering and B.S. degree in Physics from Brigham Young University. He has 30+ issued and 20+ pending U.S. patents.

vijit

Vijit Sabnis

Board Director, Ph.D.

Vijit is a venture partner at Khosla Ventures, where he focuses on emerging physical and life science technologies spanning a broad range of sectors including consumer, health, energy, sustainability, computation and communications. Prior to Khosla Ventures, Vijit was a co-founder and the CEO of Solar Junction, a manufacturer of high-efficiency multi-junction solar cells. The company was later acquired by Taqnia International. Previously, Vijit was an early employee at Translucent, a startup developing advanced semiconductor technologies for the electronics and photonics markets. While he was a graduate student at Stanford, Vijit helped incubate a new laser technology that led to the formation of the Santur Corporation. Vijit holds a bachelor’s of science degree in electrical engineering and computer science with highest honors from the University of California, Berkeley. He also holds a M.S. and a Ph.D. in electrical engineering from Stanford University.

Scientific Advisory Board

Daniel (1)

Daniel W. Chan

Ph.D., DABCC, FACB

Dr. Daniel W. Chan is Professor of Pathology, Oncology, Radiology and Urology, the Director of Center for Biomarker Discovery and Translation at the Johns Hopkins University. He is also the Director of Clinical Chemistry Division and the Co-Director of Pathology Core Laboratory at the Johns Hopkins Hospital. He is an internationally recognized expert in cancer biomarkers, clinical proteomics and molecular diagnostics. He has written 5 books, 40 book chapters and 300 scientific articles. The focus of Dr. Chan’s research is the development and application of proteomic and immunologic techniques in the diagnosis, management, and understanding of cancer. He is an internationally recognized expert in immunoassay, clinical proteomics, and biochemical tumor markers, particularly prostate, and ovarian cancer biomarkers. Dr. Chan received his Ph.D. from the State University of New York at Buffalo.

Philip

Philip C. Mack

Ph.D.

Dr. Phil Mack is a professor and Director of Molecular Pharmacology at UC Davis. He conducts molecular biology and molecular pharmacology studies for the UC Davis Cancer Center, the California Cancer Consortium, and the Southwest Oncology Group. For the past twelve years, Dr. Mack has conducted basic and translational research, with an emphasis on lung cancer. His investigations include molecular and cellular effects of novel anticancer agents in lung cancer models. Dr. Mack is Director of the UC Davis Cancer Center Molecular Pharmacology shared resource, Director of Basic Sciences for the California Cancer Consortium and Associate Director of the Southwest Oncology Group Lung Translational Medicine Committee. Dr. Mack received his Ph.D. from UC Davis.

BoxerJuly-2006

Steven Boxer

Ph.D.

Dr. Steven Boxer is the Camille and Henry Dreyfus Professor in the Department of Chemistry at Stanford University. His research interests are at the interface of physical chemistry, biology and engineering. He is an elected Fellow of the American Academy of Arts and Sciences (1997), the American Association for the Advancement of Sciences (1997) and of the Biophysical Society (2007). He received the 2008 Plyler Prize from the American Physical Society, Max Tishler Award from Tufts University, an American Chemical Society Cope Scholar Award, and the American Society for Photobiology Research Award, and has presented many named lectureships all over the world. He is the author of more than 250 publications all of which can be found on his web site. He received his Ph.D. from the University of Chicago.

Investors

Khosla Ventures

Cenova Ventures

Samsung Catalyst Fund

Cowin Venture